Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury via multiple mechanisms

BACKGROUND: Myocardial infarction (MI) is a serious cardiovascular disease associated with myocardial ischemia/reperfusion (I/R) injury. Dexmedetomidine (Dex), an α2‐adrenoceptor agonist, has been reported to protect against I/R injury. We examined the cardioprotective effects of Dex on cardiomyocyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Shunv, Liu, Yixing, Cheng, Yun, Yuan, Junbo, Fang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279977/
https://www.ncbi.nlm.nih.gov/pubmed/34882841
http://dx.doi.org/10.1002/jcla.24119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279977/
https://www.ncbi.nlm.nih.gov/pubmed/34882841
http://dx.doi.org/10.1002/jcla.24119

Ejemplares similares